About Richard Warburg
Richard Warburg is a director at Kaida BioPharma.
Form D filings also name Richard Warburg as a director at Zetagen Therapeutics and Cristcot.
Richard Warburg first appears on SEC filings in 2019.
Experience
This experience comes from Richard Warburg's profile and from SEC filings. For roles taken from filings, the years are when the filings name Richard Warburg in the role, so the role may have started earlier or lasted longer.
TC
The Tiny Cargo Company Current
Member Board of Directors
2025 – Present
EL
eLux Current
Chairperson of the Board
2023 – Present
VE
VERIGRAFT Current
Board Of Directors
2019 – Present
EI
Enterin Inc. Current
Board of Directors Observer
2018 – Present
ST
Smartech Topical Current
Member Board of Directors
2018 – Present
RI
Rose Pharma Inc. Current
Board Of Directors
2017 – Present
S3
Scientia Ventures Fund 3 Current
Management Team
2016 – Present
VL
VALLEY OILS PARTNERS, LLC Current
Member Board of Directors
2014 – Present
GH
Godney Holdings Current
Owner & Principal
2010 – Present
AT
Auven Therapeutics
Partner
2010 – 2019
FL
Foley & Lardner LLP
Partner
2001 – 2010
LL
Lyon & Lyon
Partner
1990 – 2000
Key Colleagues at Startups
The people Richard Warburg works with at each company, as listed on that company's latest Form D.
Kaida BioPharma Inc. · Form D/A, Sep 1, 2026
CP
Craig Pierson
President and director
SV
Stella Vnook
Director
Zetagen Therapeutics, Inc. · Form D/A, Nov 12, 2025
JL
Joe Loy
Executive officer and director
AK
Ashok Kaveeshwar
Director
PF
Peter Finn
Secretary
NM
Nikhil Thakur, MD
Executive officer and director
DB
Donald Brown
Director
Cristcot LLC · Form D, Jun 6, 2025
MK
Marc Keller
Director
EP
Ernest Pomerantz
Director
HK
Henry Kay
Director
JD
Jennifer Davagian
Executive officer and director
DS
David Shepherd
Director
JD
John Davagian
Director